RecruitingNot ApplicableNCT07063420
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers: A Pilot Study
Sponsor
Daniel Chernavvsky, MD
Enrollment
18 participants
Start Date
Oct 28, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Age ≥18.0 years old at time of consent.
- Clinical diagnosis, based on investigator assessment, of type 2 diabetes for at least 6 months.
- Hemoglobin A1c (HbA1c) ≥ 7.0%.
- Currently using an approved long-acting insulin for at least 3 months (e.g., insulin glargine, insulin degludec).
- Treated or about to be treated with multi-drug therapies for T2D.
- If using a CGM, willingness to wear an additional study CGM during the duration of the study.
- Access to the internet and willingness to upload data during the study as needed.
- If female and sexually active, must agree to use a form of contraception to prevent pregnancy while a participant in the study. A negative serum or urine pregnancy test will be required for all females who self-report that they are of childbearing potential. Participants who become pregnant will be discontinued from the study. Also, participants who during the study develop and express the intention to become pregnant within the timespan of the study will be discontinued.
Exclusion Criteria9
- Currently using rapid insulin for at least three months (e.g., insulin aspart, insulin lispro, insulin regular).
- Currently being treated for a seizure disorder.
- A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol, such as but not limited to, the following examples:
- Seizure disease
- Decompensated cardiac disease
- Inpatient psychiatric treatment in the past 6 months
- Presence of a known adrenal disorder
- Currently pregnant or intent to become pregnant during the trial.
- Anticipated surgical, interventional procedures or prolonged periods of fasting during this study.
Interventions
OTHERContinuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS)
Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) PCM-DSS
OTHERContinuous Glucose Monitor (CGM) + Usual Care
Continuous Glucose Monitor (CGM) + Usual Care (Physician)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07063420
Related Trials
Closed-loop in Adults With Type 2 Diabetes
NCT0657940412 locations
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
NCT061852961 location
Continuous Glucose Monitor Use in Pregnancy
NCT053175851 location
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
NCT057954391 location